粉样蛋白病理和异常的神经活动如何破坏阿尔茨海默病中的可塑性和记忆力?
1Department of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, USA.
概括
阿尔茨海默病涉及网络干扰,其中粉样β会导致神经元过活,损害记忆形成和回忆. 细胞问题创造了一个对可塑性的敌对环境,影响认知功能.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 认知科学 认知科学
背景情况:
- 阿尔茨海默病 (AD) 越来越多地被视为影响可塑性的网络障碍.
- 粉样蛋白-β和tau病理破坏了记忆引擎机制.
研究的目的:
- 审查粉样β驱动的神经元过活性如何导致阿尔茨海默病患者的记忆缺陷.
- 讨论细胞病理的相互作用及其对神经可塑性的影响.
- 为了将电路级干扰与内存故障联系起来,并评估AD小鼠模型.
主要方法:
- 对阿尔茨海默病研究的文献综述.
- 在AD中分析网络状态和可塑性容量.
- 检查细胞和电路水平的干扰.
主要成果:
- 粉样β驱动的神经元过度活动会损害可塑性和记忆力.
- 相互作用的细胞病理创造了一个不容塑性的环境.
- 记忆编码,巩固和回忆中的故障与高活性和低活性神经元群体有关.
结论:
- 阿尔茨海默病涉及复杂的网络和细胞功能障碍影响记忆.
- 粉样β在神经元过活性的作用是认知衰退的核心.
- 需要进一步研究目前用于AD研究的动物模型的局限性.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


